Medicinal Product Shortages - update - 13th July 2022

Notice type: Advisory

Date: 13/07/2022


Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Antabuse 400mg Effervescent Tablets - PA1380/008/001
  • Centrax 10mg Tablets - PA0822/010/001
  • Fentanyl 100mcg in 2ml Solution for Injection - PA0073/122/001
  • Fentanyl 500mcg in 10ml Solution for Injection - PA0073/122/002
  • Lyrica 25mg hard Capsules (56 pack) - EU/1/04/279/003
  • Orencia Solution for injection in Pre-Filled Syringe- EU/1/07/389/008
  • Osteomel Once Weekly 70mg Tablets - PA0126/148/002
  • Ozempic 0.25mg Solution for Injection in Pre-Filled Pen - EU/1/17/1251/002
  • Palexia 100mg Film Coated Tablets - PA2242/012/003
  • Prednisolone 1mg Tablets - PA0126/027/002
  • Prednisolone 5mg Tablets - PA0126/027/001
  • Retrovir 100mg/10ml Oral Solution - PA22575/001/002
  • Rotarix - EU/1/05/330/010


The following shortages have been resolved and supply has resumed to the Irish market:

  • Cholestagel 625mg Film Coated Tablets - EU/1/03/268/1-3
  • Entecavir Rowex 0.5mg Film Coated Tablets - PA0711/274/001
  • Flutiform 50mcg/5mcg per metered dose Pressurised Inhalation - PA1688/013/001
  • Glycopyrronium bromide 200mcg/ml Solution for Injection (3ml) - PA0857/001/001
  • Lenzetto 1.53mg/spray, Transdermal Spray- PA1330/017/001
  • Neoclarityn 0.5mg/ml Oral Solution (150ml) - EU/1/00/161/067
  • Triapin 2.5mg/2.5mg Prolonged Release Tablet - PA0540/082/001


Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back